Velsipity

one white and yellow capsule farther ahead than four other same-colored blue capsules

Marketing

Pfizer's Velsipity faces stiff competition in UC market: reports

In its first few months, Pfizer’s Velsipity has already made a splash in the ulcerative colitis space, where it’s up against fellow S1P Zeposia.

Andrea Park Apr 4, 2024 12:14pm

Zeposia

BMS' Zeposia comes up short in Crohn's disease study

Mar 29, 2024 8:15am

Pfizer

Pfizer wins FDA approval to challenge BMS in ulcerative colitis

Oct 13, 2023 9:36am

topic report

Pharma cash

Top 10 most anticipated drug launches of 2023

Feb 6, 2023 3:00am